๐ S2B Scale-up Case: JNP Medi’s 1,865x Growth
JNP Medi, a digital clinical trial and data management service provider, achieved an astonishing 1,865x growth in just two years. This success was driven by strategic investments through Shinhan’s dedicated fund and a global market expansion strategy.
๐ JNP Medi’s Growth Achievements
โ
Total Investment Secured: KRW 14 billion ($10M)
โ
2023 Revenue: KRW 1 billion ($750K)
โ
Corporate Valuation Growth: 1,865x increase in two years
๐ The valuation graph shows a steep rise, particularly in years 3–4, reaching nearly KRW 50 billion ($37M).
๐ฅ Two-Year Growth Program: Incubation-Driven Strategy
JNP Medi’s rapid scale-up was enabled by a two-year customized support program, focusing on incubation and strategic investments.
๐ฏ Key Support Initiatives
โ๏ธ Business & R&D strategy development tailored to each growth stage
โ๏ธ Direct & indirect investments through Shinhan’s dedicated fund
โ๏ธ Global expansion support via partnerships & marketing initiatives
This structured support provided the foundation for JNP Medi to scale quickly and enter global markets.
๐ Global Expansion & Future Outlook
JNP Medi is rapidly expanding in the digital clinical trial and data management sector worldwide. Investment and marketing support through Shinhan’s dedicated fund have been key drivers of its international growth.
This case clearly demonstrates how structured support and investment strategies can drive hypergrowth for startups.
๐ Key Takeaways for Startup Scale-up
โ
Develop phased growth strategies for structured business expansion
โ
Secure stable funding by collaborating with trusted investment partners
โ
Leverage marketing & partnerships to penetrate global markets
JNP Medi’s unprecedented growth in just two years proves that focused support and strategic investment can lead to exponential startup success. ๐
๐ S2B Scale-up Case: JNP Medi’s 1,865x Growth
JNP Medi, a digital clinical trial and data management service provider, achieved an astonishing 1,865x growth in just two years. This success was driven by strategic investments through Shinhan’s dedicated fund and a global market expansion strategy.
๐ JNP Medi’s Growth Achievements
โ Total Investment Secured: KRW 14 billion ($10M)
โ 2023 Revenue: KRW 1 billion ($750K)
โ Corporate Valuation Growth: 1,865x increase in two years
๐ The valuation graph shows a steep rise, particularly in years 3–4, reaching nearly KRW 50 billion ($37M).
๐ฅ Two-Year Growth Program: Incubation-Driven Strategy
JNP Medi’s rapid scale-up was enabled by a two-year customized support program, focusing on incubation and strategic investments.
๐ฏ Key Support Initiatives
โ๏ธ Business & R&D strategy development tailored to each growth stage
โ๏ธ Direct & indirect investments through Shinhan’s dedicated fund
โ๏ธ Global expansion support via partnerships & marketing initiatives
This structured support provided the foundation for JNP Medi to scale quickly and enter global markets.
๐ Global Expansion & Future Outlook
JNP Medi is rapidly expanding in the digital clinical trial and data management sector worldwide. Investment and marketing support through Shinhan’s dedicated fund have been key drivers of its international growth.
This case clearly demonstrates how structured support and investment strategies can drive hypergrowth for startups.
๐ Key Takeaways for Startup Scale-up
โ Develop phased growth strategies for structured business expansion
โ Secure stable funding by collaborating with trusted investment partners
โ Leverage marketing & partnerships to penetrate global markets
JNP Medi’s unprecedented growth in just two years proves that focused support and strategic investment can lead to exponential startup success. ๐